287 results on '"Molderings, Gerhard J."'
Search Results
2. Cluster-Analytic Identification of Clinically Meaningful Subtypes in MCAS: The Relevance of Heat and Cold
3. Correction : Health-related quality of life and health literacy in patients with systemic mastocytosis and mast cell activation syndrome
4. Efficacy and toxicity of hydroxyurea in mast cell activation syndrome patients refractory to standard medical therapy: retrospective case series
5. Systemic mast cell activation disease variants and certain genetically determined comorbidities may be consequences of a common underlying epigenetic disease
6. Gastrointestinale Erscheinungsformen der systemischen Mastzellaktivierungserkrankung – Eine praxisorientierte Einführung in Klinik, Diagnostik und Therapie.
7. Health-related quality of life and health literacy in patients with systemic mastocytosis and mast cell activation syndrome
8. Mast cell activation symptoms are prevalent in Long-COVID
9. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome
10. Case report: Auditory neuropathy in systemic mast cell activation disease
11. Mast Cell Activation Syndrome: A Primer for the Gastroenterologist
12. Learned cautions regarding antibody testing in mast cell activation syndrome
13. Cardiovascular symptoms in patients with systemic mast cell activation disease
14. Transgenerational transmission of systemic mast cell activation disease—genetic and epigenetic features
15. Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseases
16. Mutational profiling in the peripheral blood leukocytes of patients with systemic mast cell activation syndrome using next-generation sequencing
17. The genetic basis of mast cell activation disease - looking through a glass darkly
18. Siglec-8 as mast cell selective target: developing paradigms amidst inconvenient truths
19. Pharmacological treatment options for mast cell activation disease
20. Agmatine: clinical applications after 100 years in translation
21. Investigation into mechanisms mediating the inhibitory effect of 1,4-benzodiazepines on mast cells by gene expression profiling
22. Inhibitory effects of benzodiazepines on the adenosine A2B receptor mediated secretion of interleukin-8 in human mast cells
23. Agmatine (decarboxylated l-arginine): Physiological role and therapeutic potential
24. Commentary: Condition Is Often Overlooked
25. Effects of exogenous agmatine in human leukemia HMC-1 and HL-60 cells on proliferation, polyamine metabolism and cell cycle
26. Evaluation of a tryptase depletion index for better pathologic identification of mast cell activation syndrome
27. Restless legs syndrome is associated with long-COVID in women
28. Evidence for contribution of epigenetic mechanisms in the pathogenesis of systemic mast cell activation disease
29. Evaluation of a tryptase depletion index for better pathologic identification of mast cell activation syndrome.
30. Successful treatment of mast cell activation syndrome with sunitinib
31. Intravenous infusion of ascorbic acid decreases serum histamine concentrations in patients with allergic and non-allergic diseases
32. Die systemische Mastozytose – Standortbestimmung einer internistischen Erkrankung
33. Effects of Primary Mast Cell Disease on Hemostasis and Erythropoiesis
34. Regulatory mechanisms underlying agmatine homeostasis in humans
35. S1P-receptors in PC12 and transfected HEK293 cells: Molecular targets of hypotensive imidazoline I 1 receptor ligands
36. Dysferlinopathie als extrahepatische Ursache von Transaminasenerhöhungen
37. Agmatine (decarboxylated arginine), a modulator of liver cell homeostasis and proliferation
38. Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics
39. Potential Relevance of Agmatine as a Virulence Factor of Helicobacter pylori
40. Toward a global classification of mast cell activation diseases
41. Small Intestinal Bacterial Overgrowth is Common in Mast Cell Activation Syndrome
42. Mast Cell Activation Syndrome: A Primer for the Gastroenterologist
43. Diagnosis of mast cell activation syndrome: a global “consensus-2”
44. Restless legs syndrome is associated with mast cell activation syndrome
45. Ureteral stones due to systemic mastocytosis: diagnostic and therapeutic characteristics
46. New aspects of liver abnormalities as part of the systemic mast cell activation syndrome
47. S1P-receptors in PC12 and transfected HEK293 cells: Molecular targets of hypotensive imidazoline I1 receptor ligands
48. [3H]Idazoxan binding to bovine adrenal medullary membranes: identification and pharmacological characterization of I2-imidazoline sites
49. Binding of [3H]clonidine to I1-imidazoline sites in bovine adrenal medullary membranes
50. Intestinal tumor and agmatine (decarboxylated arginine): low content in colon carcinoma tissue specimens and inhibitory effect on tumor cell proliferation in vitro
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.